Today, the Ride for Roswell, presented by the West Herr Automotive Group, announced the date for the 2021 Ride for Roswell, which will take place on Saturday, August 7.

Roswell Park Comprehensive Cancer Center’s Igor Puzanov, MD, MSCI, FACP, Andrew Hyland, PhD, and Maciej Goniewicz, PhD, PharmD, have all recently been recognized as global scientific pioneers on Clarivate Plc’s Highly Cited Researchers list for 2020.

Roswell Park’s Francisco J. Hernandez-Ilizaliturri, MD, has been investigating a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Dr. Hernandez-Ilizaliturri is presenting the team’s findings at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.

A group of researchers led by Roswell Park's Maximillian Merz, MD, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either relapsed/refractory or newly diagnosed multiple myeloma and is presenting the findings at ASH 2020.